From 10:00 to 24:00 on July 30, the No. 4 Division of the Fourth Division of the Xinjiang Production and Construction Corps added 4 asymptomatic infections

Author:Global Times Time:2022.07.31

From 10:00 to 24:00 on July 30, there were 4 cases of new native non -symptoms in the Xinjiang Production and Construction Corps of the Fourth Division of the Xinjiang Production and Construction Corps. During the screening in the management and control area Essence Relevant contact personnel have all implemented centralized isolation medical observations, and work and control of landing control and flow traceability are being carried out simultaneously.

The fourth division has set 5 high risk zones in accordance with the "New Coronatte Pneumonic Pneumonia Prevention Plan" (ninth edition), asymptomatic infected activity trajectory, and epidemic dissemination risks. Fuyu and Yu Jiayuan Community, Lane 3, Lane 5, Lane 5, No. 11 Lane 2, No. 11, Xiaolong West Street, Huocheng West Street, Lane 9 and 11, Lane of Huocheng East Street in Guangming Community; Division 62, Lane 3, Lane 5, Lane 7, Lane 5, Lane 7, Lane, Lane Southeast District, Low -risk Zone: In addition to divided into 62 regiments outside the middle and high -risk areas. High -risk zones adopt control measures such as "not leaving home and on -site services", and the central risk zone adopts control measures such as "no regions, peaks from peaks". Measures are not necessary to leave the regiment. It is necessary to leave the group for 48 hours of kernel acid test negative proof. (The reporter Tian Tong Bupeng Zhang Min Alman)

Source: CCTV News Client

- END -

Shen Hongbing is the director of the China Centers for Disease Control and Prevention

[Dahecai Cube News] According to the China Disease Prevention and Control Center, on the afternoon of July 26, the China Centers for Disease Control and Prevention held a cadre conference. Member and

Set up seven platforms in Henan to promote high -quality development of pharmacist teams

Newspaper (Reporter Zhu Xiaojuan Xu Dongdong) In recent years, Henan Pharmaceutica...